Cargando…
Assessment of Different Circulating Tumor Cell Platforms for Uveal Melanoma: Potential Impact for Future Routine Clinical Practice
Liquid biopsy and circulating tumor cell (CTC) screening has gained interest over the last two decades for detecting almost all solid malignancies. To date, the major limitation in terms of the applicability of CTC screening in daily clinical practice is the lack of reproducibility due to the high n...
Autores principales: | Martel, Arnaud, Mograbi, Baharia, Romeo, Barnabe, Gastaud, Lauris, Lalvee, Salome, Zahaf, Katia, Fayada, Julien, Nahon-Esteve, Sacha, Bonnetaud, Christelle, Salah, Myriam, Tanga, Virginie, Baillif, Stéphanie, Bertolotto, Corine, Lassalle, Sandra, Hofman, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342234/ https://www.ncbi.nlm.nih.gov/pubmed/37446253 http://dx.doi.org/10.3390/ijms241311075 |
Ejemplares similares
-
Need for a Dedicated Ophthalmic Malignancy Clinico-Biological Biobank: The Nice Ocular MAlignancy (NOMA) Biobank
por: Martel, Arnaud, et al.
Publicado: (2023) -
Liquid Biopsy for Solid Ophthalmic Malignancies: An Updated Review and Perspectives
por: Martel, Arnaud, et al.
Publicado: (2020) -
New Targeted Therapies and Immunotherapies for Locally Advanced Periocular Malignant Tumours: Towards a New ‘Eye-Sparing’ Paradigm?
por: Martel, Arnaud, et al.
Publicado: (2021) -
Small but Challenging Conjunctival Melanoma: New Insights, Paradigms and Future Perspectives
por: Nahon-Estève, Sacha, et al.
Publicado: (2021) -
Prognostic Biomarkers in Uveal Melanoma: The Status Quo, Recent Advances and Future Directions
por: Lamas, Nuno Jorge, et al.
Publicado: (2021)